EVMN vs FBLG

Evommune, Inc. vs FibroBiologics, Inc. — Valuation Comparison 2026

EVMN

Pharmaceutical Preparations
Evommune, Inc.
Quality
6.0
out of 10
Value Trap
Price
$23.23
Last close
Models
9/13
Active
VS

FBLG

Pharmaceutical Preparations
FibroBiologics, Inc.
Quality
4.1
out of 10
Value Trap
6
SAFE
Price
$1.16
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType EVMN Fair ValueEVMN Upside FBLG Fair ValueFBLG Upside
Bayesian DCF Intrinsic $3.72 -84.0% $0.22 -80.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $2.55 -89.6% $1.70 +46.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for EVMN vs FBLG — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EVMN vs FBLG — Which Stock Is More Undervalued?

EVMN scores higher with a 6.0/10 quality rating vs FBLG's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Evommune, Inc. (EVMN) and FibroBiologics, Inc. (FBLG) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EVMN currently trades at $23.23 with a QOC of 6.0/10, while FBLG trades at $1.16 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).